Literature DB >> 19683471

Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation.

Jean-François Tanti1, Jennifer Jager.   

Abstract

Insulin receptor substrates (IRS) serine phosphorylation is a time-controlled physiological feedback mechanism in insulin signaling that is hijacked by metabolic and inflammatory stresses to promote insulin resistance. Kinases, including IKKbeta, JNK, ERK, mTOR, and S6K, activated by the inducers of insulin resistance induce uncontrolled IRS serine phosphorylation. Studies with genetically modified mice reveal that these kinases integrate signals from metabolic and inflammatory stresses in adipose tissue, liver, and hypothalamus leading to peripheral and central insulin resistance. Moreover, IKKbeta/NF-kappaB and JNK1 pathways in myeloid cells represent a core mechanism involved in inflammation linked to obesity. These kinases are thus potential drug targets against insulin resistance and the targeting of the IKKbeta/NF-kappaB or the JNK pathway may evolve into future diabetes medication.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19683471     DOI: 10.1016/j.coph.2009.07.004

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  139 in total

Review 1.  cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance.

Authors:  Guadalupe Sabio; Roger J Davis
Journal:  Trends Biochem Sci       Date:  2010-05-07       Impact factor: 13.807

Review 2.  Linking mitochondrial bioenergetics to insulin resistance via redox biology.

Authors:  Kelsey H Fisher-Wellman; P Darrell Neufer
Journal:  Trends Endocrinol Metab       Date:  2012-02-02       Impact factor: 12.015

Review 3.  The Placenta as a Mediator of Stress Effects on Neurodevelopmental Reprogramming.

Authors:  Stefanie L Bronson; Tracy L Bale
Journal:  Neuropsychopharmacology       Date:  2015-08-07       Impact factor: 7.853

4.  Role of substance P in the regulation of glucose metabolism via insulin signaling-associated pathways.

Authors:  Iordanes Karagiannides; Kyriaki Bakirtzi; Efi Kokkotou; Dimitris Stavrakis; Kara Gross Margolis; Thomas Thomou; Nino Giorgadze; James L Kirkland; Charalabos Pothoulakis
Journal:  Endocrinology       Date:  2011-10-18       Impact factor: 4.736

5.  Maternal selenium status is profoundly involved in metabolic fetal programming by modulating insulin resistance, oxidative balance and energy homeostasis.

Authors:  María Luisa Ojeda; Fátima Nogales; Alba Membrilla; Olimpia Carreras
Journal:  Eur J Nutr       Date:  2018-12-01       Impact factor: 5.614

Review 6.  NOD1: An Interface Between Innate Immunity and Insulin Resistance.

Authors:  Sydney L Rivers; Amira Klip; Adria Giacca
Journal:  Endocrinology       Date:  2019-05-01       Impact factor: 4.736

Review 7.  Interaction between hepatitis C virus and metabolic factors.

Authors:  Yasunori Kawaguchi; Toshihiko Mizuta
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

8.  A Novel Class of Common Docking Domain Inhibitors That Prevent ERK2 Activation and Substrate Phosphorylation.

Authors:  Rachel M Sammons; Nicole A Perry; Yangmei Li; Eun Jeong Cho; Andrea Piserchio; Diana P Zamora-Olivares; Ranajeet Ghose; Tamer S Kaoud; Ginamarie Debevec; Chandra Bartholomeusz; Vsevolod V Gurevich; Tina M Iverson; Marc Giulianotti; Richard A Houghten; Kevin N Dalby
Journal:  ACS Chem Biol       Date:  2019-05-13       Impact factor: 5.100

9.  Medium-chain triglyceride ameliorates insulin resistance and inflammation in high fat diet-induced obese mice.

Authors:  Shanshan Geng; Weiwei Zhu; Chunfeng Xie; Xiaoting Li; Jieshu Wu; Zhaofeng Liang; Wei Xie; Jianyun Zhu; Cong Huang; Mingming Zhu; Rui Wu; Caiyun Zhong
Journal:  Eur J Nutr       Date:  2015-04-25       Impact factor: 5.614

10.  High-Fat-Diet-Induced Deficits in Dopamine Terminal Function Are Reversed by Restoring Insulin Signaling.

Authors:  Steve C Fordahl; Sara R Jones
Journal:  ACS Chem Neurosci       Date:  2017-01-03       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.